Prevention of preeclampsia with low-dose aspirin -- a systematic review and meta-analysis of the main randomized controlled trials.

Rodrigo Ruano, Rosana S. Fontes, Marcelo Zugaib

Research output: Contribution to journalReview article

52 Citations (Scopus)

Abstract

The purpose of this paper is to evaluate the effectiveness of low-dose aspirin in the prevention of preeclampsia in low-risk and high-risk women. We identified randomized clinical trials of the use of low-dose aspirin to prevent preeclampsia through the PUBMED search engine, and through the Cochran Library database. Twenty-two studies met our inclusion criteria, and were divided according to the studied population into 2 groups: trials with women at low risk for preeclampsia and trials with women at high risk. Effects were measured through the incidence of preeclampsia in women taking either placebo or aspirin, in studies where the relative risks and the 95% confidence intervals were calculated for both groups. A total of 33,598 women were studied, comprising 5 trials with 16,700 women at low-risk and 17 trials including 16,898 women at high risk. The incidence of preeclampsia was 3.75% (626/17,700), in the low-risk group, 9.01% (1,524/16,898) in the high-risk group, and 6.40% (2,150/33,598) overall. Low-dose aspirin had no statistically significantly effect on the incidence of preeclampsia in the low-risk group (RR = 0.95, 95% CI = 0.81-1.11), but had a small beneficial effect in the high-risk group (RR = 0.87, 95% CI = 0.79-0.96). Therefore, low-dose aspirin is mildly beneficial in terms of reducing the incidence of preeclampsia in women at high risk of developing preeclampsia.

Original languageEnglish (US)
Pages (from-to)407-414
Number of pages8
JournalClinics (São Paulo, Brazil)
Volume60
Issue number5
DOIs
StatePublished - Jan 1 2005
Externally publishedYes

Fingerprint

Pre-Eclampsia
Aspirin
Meta-Analysis
Randomized Controlled Trials
Incidence
Search Engine
Libraries
Placebos
Databases
Confidence Intervals

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Prevention of preeclampsia with low-dose aspirin -- a systematic review and meta-analysis of the main randomized controlled trials. / Ruano, Rodrigo; Fontes, Rosana S.; Zugaib, Marcelo.

In: Clinics (São Paulo, Brazil), Vol. 60, No. 5, 01.01.2005, p. 407-414.

Research output: Contribution to journalReview article

@article{31095c15b42c4f95b08f97c291e8bdd7,
title = "Prevention of preeclampsia with low-dose aspirin -- a systematic review and meta-analysis of the main randomized controlled trials.",
abstract = "The purpose of this paper is to evaluate the effectiveness of low-dose aspirin in the prevention of preeclampsia in low-risk and high-risk women. We identified randomized clinical trials of the use of low-dose aspirin to prevent preeclampsia through the PUBMED search engine, and through the Cochran Library database. Twenty-two studies met our inclusion criteria, and were divided according to the studied population into 2 groups: trials with women at low risk for preeclampsia and trials with women at high risk. Effects were measured through the incidence of preeclampsia in women taking either placebo or aspirin, in studies where the relative risks and the 95{\%} confidence intervals were calculated for both groups. A total of 33,598 women were studied, comprising 5 trials with 16,700 women at low-risk and 17 trials including 16,898 women at high risk. The incidence of preeclampsia was 3.75{\%} (626/17,700), in the low-risk group, 9.01{\%} (1,524/16,898) in the high-risk group, and 6.40{\%} (2,150/33,598) overall. Low-dose aspirin had no statistically significantly effect on the incidence of preeclampsia in the low-risk group (RR = 0.95, 95{\%} CI = 0.81-1.11), but had a small beneficial effect in the high-risk group (RR = 0.87, 95{\%} CI = 0.79-0.96). Therefore, low-dose aspirin is mildly beneficial in terms of reducing the incidence of preeclampsia in women at high risk of developing preeclampsia.",
author = "Rodrigo Ruano and Fontes, {Rosana S.} and Marcelo Zugaib",
year = "2005",
month = "1",
day = "1",
doi = "10.1590/S1807-59322005000500010",
language = "English (US)",
volume = "60",
pages = "407--414",
journal = "Clinics",
issn = "1807-5932",
publisher = "University of Sao Paolo",
number = "5",

}

TY - JOUR

T1 - Prevention of preeclampsia with low-dose aspirin -- a systematic review and meta-analysis of the main randomized controlled trials.

AU - Ruano, Rodrigo

AU - Fontes, Rosana S.

AU - Zugaib, Marcelo

PY - 2005/1/1

Y1 - 2005/1/1

N2 - The purpose of this paper is to evaluate the effectiveness of low-dose aspirin in the prevention of preeclampsia in low-risk and high-risk women. We identified randomized clinical trials of the use of low-dose aspirin to prevent preeclampsia through the PUBMED search engine, and through the Cochran Library database. Twenty-two studies met our inclusion criteria, and were divided according to the studied population into 2 groups: trials with women at low risk for preeclampsia and trials with women at high risk. Effects were measured through the incidence of preeclampsia in women taking either placebo or aspirin, in studies where the relative risks and the 95% confidence intervals were calculated for both groups. A total of 33,598 women were studied, comprising 5 trials with 16,700 women at low-risk and 17 trials including 16,898 women at high risk. The incidence of preeclampsia was 3.75% (626/17,700), in the low-risk group, 9.01% (1,524/16,898) in the high-risk group, and 6.40% (2,150/33,598) overall. Low-dose aspirin had no statistically significantly effect on the incidence of preeclampsia in the low-risk group (RR = 0.95, 95% CI = 0.81-1.11), but had a small beneficial effect in the high-risk group (RR = 0.87, 95% CI = 0.79-0.96). Therefore, low-dose aspirin is mildly beneficial in terms of reducing the incidence of preeclampsia in women at high risk of developing preeclampsia.

AB - The purpose of this paper is to evaluate the effectiveness of low-dose aspirin in the prevention of preeclampsia in low-risk and high-risk women. We identified randomized clinical trials of the use of low-dose aspirin to prevent preeclampsia through the PUBMED search engine, and through the Cochran Library database. Twenty-two studies met our inclusion criteria, and were divided according to the studied population into 2 groups: trials with women at low risk for preeclampsia and trials with women at high risk. Effects were measured through the incidence of preeclampsia in women taking either placebo or aspirin, in studies where the relative risks and the 95% confidence intervals were calculated for both groups. A total of 33,598 women were studied, comprising 5 trials with 16,700 women at low-risk and 17 trials including 16,898 women at high risk. The incidence of preeclampsia was 3.75% (626/17,700), in the low-risk group, 9.01% (1,524/16,898) in the high-risk group, and 6.40% (2,150/33,598) overall. Low-dose aspirin had no statistically significantly effect on the incidence of preeclampsia in the low-risk group (RR = 0.95, 95% CI = 0.81-1.11), but had a small beneficial effect in the high-risk group (RR = 0.87, 95% CI = 0.79-0.96). Therefore, low-dose aspirin is mildly beneficial in terms of reducing the incidence of preeclampsia in women at high risk of developing preeclampsia.

UR - http://www.scopus.com/inward/record.url?scp=33645734737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645734737&partnerID=8YFLogxK

U2 - 10.1590/S1807-59322005000500010

DO - 10.1590/S1807-59322005000500010

M3 - Review article

C2 - 16254678

AN - SCOPUS:33645734737

VL - 60

SP - 407

EP - 414

JO - Clinics

JF - Clinics

SN - 1807-5932

IS - 5

ER -